Finance

Lists
600867:SHA
Tonghua Dongbao Pharmaceutical Co Ltd
CNÂ¥7.72
-1.66%
(-0.13) 1D
Oct 15, 2:48:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600867...
Open
CNÂ¥7.80
High
CNÂ¥7.88
Low
CNÂ¥7.71
Mkt. cap
15.37B
Avg. vol.
13.50M
Volume
12.76M
Dividend
3.89%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 5, 2026
P/E ratio
11.63
52-wk high
CNÂ¥10.67
52-wk low
CNÂ¥7.16
EPS
CNÂ¥0.66
Shares outstanding
2.03B
No. of employees
3K
Open
CNÂ¥7.80
High
CNÂ¥7.88
Low
CNÂ¥7.71
Mkt. cap
15.37B
Avg. vol.
13.50M
Volume
12.76M
Dividend
3.89%
Quarterly dividend
CNÂ¥0.08
Ex-dividend date
Jun 5, 2026
P/E ratio
11.63
52-wk high
CNÂ¥10.67
52-wk low
CNÂ¥7.16
EPS
CNÂ¥0.66
Shares outstanding
2.03B
No. of employees
3K
News stories
From web sources and news partners
About Tonghua Dongbao Pharmaceutical Co Ltd
CEO-
Employees3.35K
Founded1985
Headquarters-
SectorPharmaceutical industry
Websitethdb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
806.10M
767.64M
747.65M
805.18M
Cost of goods sold
220.63M
273.45M
212.16M
259.79M
Cost of revenue
220.63M
273.45M
212.16M
259.79M
Research and development expenses
35.78M
50.69M
35.81M
39.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
344.63M
275.71M
337.36M
344.32M
Operating expense
390.97M
336.75M
377.09M
386.31M
Total operating expenses
611.59M
610.21M
589.25M
646.10M
Operating income
194.50M
157.43M
158.40M
159.08M
Other non operating income
-19.21M
-701.80K
-138.08K
-1.67M
EBT including unusual items
1.17B
36.69M
166.32M
182.67M
EBT excluding unusual items
1.28B
159.07M
167.61M
179.96M
Income tax expense
206.00M
27.37M
44.93M
34.39M
Effective tax rate
17.67%
74.60%
27.01%
18.83%
Other operating expenses
10.67M
10.44M
2.16M
2.96M
Net income
984.48M
16.82M
126.80M
168.90M
Net profit margin
122.13%
2.19%
16.96%
20.98%
Earnings per share
-
-
-
-
Interest and investment income
1.11B
8.08M
13.26M
26.94M
Interest expense
-5.68M
-5.12M
-3.91M
-5.11M
Net interest expenses
1.10B
2.96M
9.35M
21.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
241.25M
223.00M
223.97M
231.48M
Gain or loss from assets sale
1.74K
3.12M
-
516.05K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps